BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 23257406)

  • 1. Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil.
    Akthar M; Nair N; Carter LM; Vital EM; Sutton E; McHugh N; ; ; Bruce IN; Reynolds JA
    Arthritis Res Ther; 2023 Jun; 25(1):111. PubMed ID: 37391799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effects of immunosuppressive therapy in autoimmune disease.
    Clemmer JS; Hillegass WB; Taylor EB
    J Hum Hypertens; 2023 Apr; 37(4):300-306. PubMed ID: 35396536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post reversible encephalopathy syndrome attributed to mycophenolate mofetil used in the treatment of SLE: A case report and review of literature.
    Dai Y; Liu W; Hong F
    J Int Med Res; 2024 Jan; 52(1):3000605231218620. PubMed ID: 38156668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined immunosuppression with cyclosporin A, mycophenolate mofetil (MMF) and dexamethasone for activity control of recurrent secondary hemophagocytic lymphohistiocytosis (sHLH) with underlying systemic lupus erythematosus (SLE)].
    Saleh M; Hampel K; Gerth J; Merkelbach S; Monecke A; Mügge LO
    Inn Med (Heidelb); 2024 Mar; ():. PubMed ID: 38459200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Mycophenolate Mofetil Use and Subsequent Infections Among Hospitalized Patients with Systemic Lupus Erythematosus: A Nested Case-Control Study.
    Guo Q; Zhang X; Sun S; Tang X; Shen W; Liang J; Yao G; Geng L; Ding S; Chen H; Wang H; Hua B; Zhang H; Wang D; Feng X; Sun L; Jin Z
    Rheumatol Ther; 2023 Dec; 10(6):1535-1554. PubMed ID: 37742321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A man in his forties with anaemia requiring transfusion].
    Sandnes M; Helgeland L; Johansen S; Reikvam H
    Tidsskr Nor Laegeforen; 2023 Oct; 143(15):. PubMed ID: 37874056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil.
    Akthar M; Nair N; Carter LM; Vital EM; Sutton E; McHugh N; ; ; Bruce IN; Reynolds JA
    Arthritis Res Ther; 2023 Sep; 25(1):160. PubMed ID: 37667347
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature.
    Conti F; Ceccarelli F; Perricone C; Massaro L; Cipriano E; Pacucci VA; Truglia S; Miranda F; Morello F; Alessandri C; Spinelli FR; Valesini G
    Immunol Res; 2014 Dec; 60(2-3):270-6. PubMed ID: 25468307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil and systemic lupus erythematosus: an overview.
    Pisoni CN; Karim Y; Cuadrado MJ
    Lupus; 2005; 14 Suppl 1():s9-11. PubMed ID: 15803925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil-induced erythroid hypoplasia in a patient with systemic lupus erythematosus.
    Doherty T; Austin SK; Newell B; Kiely PD
    Lupus; 2013 Feb; 22(2):213-5. PubMed ID: 23257406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity to mycophenolate mofetil in systemic lupus erythematosus: diagnostic measures and successful desensitization.
    Szyper-Kravitz M; Sheinberg P; Sidi Y; Schiffenbauer Y; Trubniykov E; Shoenfeld Y
    Int Arch Allergy Immunol; 2005 Dec; 138(4):334-6. PubMed ID: 16224194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducible erythroid aplasia caused by mycophenolate mofetil.
    Arbeiter K; Greenbaum L; Balzar E; Müller T; Hofmeister F; Bidmon B; Aufricht C
    Pediatr Nephrol; 2000 Mar; 14(3):195-7. PubMed ID: 10752755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
    Lourdudoss C; Vollenhoven Rv
    Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus.
    Riskalla MM; Somers EC; Fatica RA; McCune WJ
    J Rheumatol; 2003 Jul; 30(7):1508-12. PubMed ID: 12858449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
    Dittrich K; Ross S; Benz K; Amann K; Dötsch J
    Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.